GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (STU:TPM0) » Definitions » Cyclically Adjusted PB Ratio

Tonix Pharmaceuticals Holding (STU:TPM0) Cyclically Adjusted PB Ratio : 0.00 (As of Jun. 08, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Tonix Pharmaceuticals Holding Cyclically Adjusted PB Ratio?

As of today (2024-06-08), Tonix Pharmaceuticals Holding's current share price is €90.24. Tonix Pharmaceuticals Holding's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €624,201.00. Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:TPM0's Cyclically Adjusted PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.75
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Tonix Pharmaceuticals Holding's adjusted book value per share data for the three months ended in Mar. 2024 was €1.350. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €624,201.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tonix Pharmaceuticals Holding Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonix Pharmaceuticals Holding Cyclically Adjusted PB Ratio Chart

Tonix Pharmaceuticals Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tonix Pharmaceuticals Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio falls into.



Tonix Pharmaceuticals Holding Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=90.24/624201
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tonix Pharmaceuticals Holding's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tonix Pharmaceuticals Holding's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.35/131.7762*131.7762
=1.350

Current CPI (Mar. 2024) = 131.7762.

Tonix Pharmaceuticals Holding Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 222,750.000 101.688 288,658.639
201609 161,006.667 101.861 208,292.151
201612 120,210.000 101.863 155,511.458
201703 97,842.857 102.862 125,345.947
201706 81,708.108 103.349 104,182.658
201709 63,323.684 104.136 80,131.621
201712 53,335.897 104.011 67,573.575
201803 37,735.000 105.290 47,227.643
201806 30,820.455 106.317 38,200.947
201809 22,594.231 106.507 27,954.879
201812 12,840.123 105.998 15,962.794
201903 5,185.197 107.251 6,370.931
201906 3,579.495 108.070 4,364.712
201909 1,135.533 108.329 1,381.308
201912 198.664 108.420 241.461
202003 114.601 108.902 138.673
202006 90.783 108.767 109.987
202009 75.799 109.815 90.958
202012 69.946 109.897 83.872
202103 91.757 111.754 108.196
202106 86.505 114.631 99.443
202109 85.160 115.734 96.964
202112 78.012 117.630 87.394
202203 68.312 121.301 74.211
202206 42.589 125.017 44.892
202209 27.101 125.227 28.518
202212 15.983 125.222 16.820
202303 15.163 127.348 15.690
202306 12.046 128.729 12.331
202309 6.374 129.860 6.468
202312 1.651 129.419 1.681
202403 1.350 131.776 1.350

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tonix Pharmaceuticals Holding  (STU:TPM0) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Tonix Pharmaceuticals Holding Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonix Pharmaceuticals Holding (STU:TPM0) Business Description

Traded in Other Exchanges
Address
26 Main Street, Suite 101, Chatham, NJ, USA, 07928
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (STU:TPM0) Headlines

No Headlines